ICM
BIOL

Invenomic Capital Management’s Biolase, Inc. BIOL Stock Holding History

Invenomic Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-243
Closed -$253K – 157
2020
Q4 		$253K Buy
243
+223
+1,115% +$232K 0.06% 108
2020
Q3 		$14K Sell
20
-2
-9% -$1.4K 0.01% 129
2020
Q2 		$26K Buy
+22
New +$26K 0.02% 147